NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer
Clinical trial NCT03734809 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03734809
- Sponsor
- Chinese University of Hong Kong
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-03
- Primary completion
- 2025-01-25
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.